PHARMULA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMULA
Largest movements
- Receivables within one year -€13,292
down €13,292 (-39.5%), from €33,636 to €20,344
of which Other amounts receivable: -€22,918
- Tangible fixed assets +€1,908
up €1,908 (+167.1%), from €1,142 to €3,049
of which Other tangible fixed assets: +€2,609
- Profit (loss) carried forward -€107,528
down €107,528 (-86.5%), from €124,267 to €16,739
- Other debts +€102,478
up €102,478, from €0 to €102,478
- Tax, wage and social debts -€4,166
down €4,166 (-47.3%), from €8,801 to €4,635
of which Taxes: -€4,166
- Financial income -€1,421
no longer reported in 2025 (was €1,421)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €136,527 | €126,721 | -€9,806 | -7.2% |
| Fixed assets | 21/28 | €1,142 | €3,049 | +€1,908 | +167.1% |
| Tangible fixed assets | 22/27 | €1,142 | €3,049 | +€1,908 | +167.1% |
| Furniture and vehicles | 24 | €1,142 | €441 | -€701 | -61.4% |
| Other tangible fixed assets | 26 | - | €2,609 | +€2,609 | |
| Current assets | 29/58 | €135,385 | €123,671 | -€11,714 | -8.7% |
| Amounts receivable within one year | 40/41 | €33,636 | €20,344 | -€13,292 | -39.5% |
| Trade receivables | 40 | €10,558 | €20,184 | +€9,626 | +91.2% |
| Other amounts receivable | 41 | €23,078 | €160 | -€22,918 | -99.3% |
| Cash at bank and in hand | 54/58 | €101,749 | €103,093 | +€1,344 | +1.3% |
| Deferred charges and accrued income | 490/1 | - | €235 | +€235 | |
| Total equity and liabilities | 10/49 | €136,527 | €126,721 | -€9,806 | -7.2% |
| Equity | 10/15 | €126,667 | €19,139 | -€107,528 | -84.9% |
| Contributions | 10/11 | €2,400 | €2,400 | = | 0.0% |
| Profit (loss) carried forward | 14 | €124,267 | €16,739 | -€107,528 | -86.5% |
| Amounts payable | 17/49 | €9,859 | €107,582 | +€97,722 | +991.2% |
| Amounts payable within one year | 42/48 | €9,859 | €107,582 | +€97,722 | +991.2% |
| Trade debts | 44 | €1,058 | €468 | -€590 | -55.7% |
| Suppliers | 440/4 | €1,058 | €468 | -€590 | -55.7% |
| Taxes, remuneration and social security | 45 | €8,801 | €4,635 | -€4,166 | -47.3% |
| Taxes | 450/3 | €8,801 | €4,635 | -€4,166 | -47.3% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €0 | €102,478 | +€102,478 | |
| Turnover | 70 | €0 | - | = | |
| Goods, raw materials, services and sundry goods | 60/61 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €701 | €875 | +€174 | +24.8% |
| Other operating charges | 640/8 | - | €400 | +€400 | |
| Non-recurring operating charges | 66A | €1,209 | - | -€1,209 | |
| Gross operating margin | 9900 | €58,312 | €58,361 | +€48 | +0.1% |
| Operating profit (loss) | 9901 | €56,402 | €57,086 | +€684 | +1.2% |
| Financial income | 75/76B | €1,421 | - | -€1,421 | |
| Recurring financial income | 75 | €1,421 | - | -€1,421 | |
| Financial charges | 65/66B | €498 | €507 | +€9 | +1.9% |
| Recurring financial charges | 65 | €498 | €507 | +€9 | +1.9% |
| Profit (loss) for the period before taxes | 9903 | €57,325 | €56,579 | -€747 | -1.3% |
| Income taxes | 67/77 | €15,315 | €14,840 | -€475 | -3.1% |
| Profit (loss) for the period | 9904 | €42,011 | €41,739 | -€272 | -0.6% |
| Profit (loss) for the period to be appropriated | 9905 | €42,011 | €41,739 | -€272 | -0.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.